日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States

KTE-X19治疗美国复发/难治性B细胞急性淋巴细胞白血病成人患者的成本效益分析

Shah, Bijal D; Smith, Nathaniel J; Feng, Chaoling; Jeyakumar, Sushanth; Castaigne, Jean-Gabriel; Faghmous, Imi; Masouleh, Behzad Kharabi; Malone, Daniel C; Bishop, Michael R

Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia

接受标准化疗(含或不含吉妥珠单抗)治疗的急性髓系白血病患者进行造血干细胞移植后的预后

Pautas, Cécile; Raffoux, Emmanuel; Lambert, Juliette; Legrand, Ollivier; Chantepie, Sylvain; Gastaud, Lauris; Marolleau, Jean-Pierre; Thomas, Xavier; Turlure, Pascal; Benner, Rebecca J; Vandendries, Erik; Gogat, Karïn; Dombret, Hervé; Castaigne, Sylvie

Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone Marrow

维生素 D 受体控制急性髓系白血病和正常骨髓中的细胞干性

Etienne Paubelle, Florence Zylbersztejn, Thiago Trovati Maciel, Caroline Carvalho, Annalisa Mupo, Meyling Cheok, Liesbet Lieben, Pierre Sujobert, Justine Decroocq, Akihiko Yokoyama, Vahid Asnafi, Elizabeth Macintyre, Jérôme Tamburini, Valérie Bardet, Sylvie Castaigne, Claude Preudhomme, Hervé Dombre

Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial

吉妥珠单抗奥佐米星治疗新发急性髓系白血病:开放标签 III 期 ALFA-0701 试验的最终疗效和安全性更新

Lambert, Juliette; Pautas, Cécile; Terré, Christine; Raffoux, Emmanuel; Turlure, Pascal; Caillot, Denis; Legrand, Ollivier; Thomas, Xavier; Gardin, Claude; Gogat-Marchant, Karïn; Rubin, Stephen D; Benner, Rebecca J; Bousset, Pierre; Preudhomme, Claude; Chevret, Sylvie; Dombret, Herve; Castaigne, Sylvie

Paris MEM: a study protocol for an effectiveness and efficiency trial on the treatment of traumatic stress in France after the 2015-16 terrorist attacks

巴黎MEM:一项关于2015-16年恐怖袭击后法国创伤后应激障碍治疗有效性和效率试验的研究方案

Brunet, A; Ayrolles, A; Gambotti, L; Maatoug, R; Estellat, C; Descamps, M; Girault, N; Kalalou, K; Abgrall, G; Ducrocq, F; Vaiva, G; Jaafari, N; Krebs, M O; Castaigne, E; Hanafy, I; Benoit, M; Mouchabac, S; Cabié, M C; Guillin, O; Hodeib, F; Durand-Zaleski, I; Millet, B

Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group

急性髓系白血病随访期间IDH1/2突变等位基因负荷的临床意义:法国ALFA研究组的研究

Ferret, Yann; Boissel, Nicolas; Helevaut, Nathalie; Madic, Jordan; Nibourel, Olivier; Marceau-Renaut, Alice; Bucci, Maxime; Geffroy, Sandrine; Celli-Lebras, Karine; Castaigne, Sylvie; Thomas, Xavier; Terré, Christine; Dombret, Hervé; Preudhomme, Claude; Renneville, Aline

Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial)

法国比利时瑞士 APL 研究组(APL 2006 试验)报告称,对于接受三氧化二砷治疗的老年新诊断标准风险急性早幼粒细胞白血病患者,降低死亡率需要大幅减少化疗。

Rahmé, Ramy; Ades, Lionel; Thomas, Xavier; Guerci-Bresler, Agnès; Pigneux, Arnaud; Vey, Norbert; Raffoux, Emmanuel; Castaigne, Sylvie; Spertini, Olivier; Wittnebel, Sebastian; Marolleau, Jean Pierre; Damaj, Gandhi; Bordessoule, Dominique; Lejeune, Julie; Chevret, Sylvie; Fenaux, Pierre

Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma

一项随机、3期临床试验,比较inotuzumab ozogamicin联合利妥昔单抗与化疗联合利妥昔单抗治疗复发/难治性侵袭性B细胞非霍奇金淋巴瘤的疗效。

Dang, Nam H; Ogura, Michinori; Castaigne, Sylvie; Fayad, Luis E; Jerkeman, Mats; Radford, John; Pezzutto, Antonio; Bondarenko, Igor; Stewart, Douglas A; Shnaidman, Michael; Sullivan, Sharon; Vandendries, Erik; Tobinai, Kensei; Ramchandren, Radhakrishnan; Hamlin, Paul A; Giné, Eva; Ando, Kiyoshi

Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists

PPARγ激动剂对慢性粒细胞白血病干细胞库的侵蚀

Stéphane Prost, Francis Relouzat, Marc Spentchian, Yasmine Ouzegdouh, Joseph Saliba, Gérald Massonnet, Jean-Paul Beressi, Els Verhoeyen, Victoria Raggueneau, Benjamin Maneglier, Sylvie Castaigne, Christine Chomienne, Stany Chrétien, Philippe Rousselot, Philippe Leboulch

Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia

其他基因改变对NPM1突变细胞遗传学正常急性髓系白血病患者预后的影响

Peterlin, Pierre; Renneville, Aline; Ben Abdelali, Raouf; Nibourel, Olivier; Thomas, Xavier; Pautas, Cécile; de Botton, Stéphane; Raffoux, Emmanuel; Cayuela, Jean-Michel; Boissel, Nicolas; Terré, Christine; Celli-Lebras, Karine; Castaigne, Sylvie; Preudhomme, Claude; Gardin, Claude; Dombret, Hervé